Michiel van der Flier (Utrecht, 1970) studied medicine at Utrecht University. As a student he was a guest investigator at the Rockefeller University, New York, US. He trained as a paediatrician at the Wilhelmina Children's Hospital/UMC Utrecht and St Antonius Hospital Nieuwegein. He earned his PhD  in 2003 at Utrecht University on the thesis “VEGF in sepsis and meningitis”.  He did his subspecialty training in Paediatric Infectious Diseases and Immunology at the  Sophia Children's Hospital-ErasmusMC in Rotterdam and at the Great Ormond Street Hospital for Sick Children in Londen. From 2009 to 2018 he worked as a consultant  in Paediatric Infectious Diseases and Immunology at the Amalia Children's Hospital-Radboudumc in Nijmegen and from 2014 to 2018 he served as program manager of the subspecialty .  In 2017-2018 he worked half a year as Honorary Clinical Senior Lecturer in St Mary’s Hospital, Imperial College, in Londen. Starting November 2018 he returned to the UMC Utrecht. He combines the care for children with infections and immunodeficiencies  in the Wilhelmina Children's Hospital and the Princess Maxima Centre for Paediatric Oncology with research and teaching.  

2020         Wilhelmina Research Fund Grant 2019-2020

2006         ESPID Fellowship

1998         AGIKO Stipendium ZonMw

1995         WKZ Award “Best student researchproject"

1993         Free-Mover Stipendium STIR-fund

Research Grants (selection)

2023-present             Effect of Anti-Group B streptococcus (GBS) monoclonal antibodies in human (preterm) neonatal anti-GBS host defense assays. Minervax.  PI

2021-present             RUBY (Rna umbilical cord blood sepsis diagnosis in newborn baby’s) Elisabeth von Freyburg Fund  PI

2021-2023                        Boosting host-defence to protect against neonatal GBS sepsis. Vaillant Fund 

2020-present                    DIAMONDS (Diagnosis and Management Of febrile illness using RNA Personalized Molecular Signature Diagnosis) EU H2020 project PI UMCUtrecht Co-lead Clinical working Party Immunocompromised patients.

2020-2024                PEARLS       (Boosting host-defence to prevent and treat neonatal sepsis) WKZ Research fund 

2017-present           Exhaled breath analysis to distinguish viral from bacterial aetiology of lower respiratory tract infections in children. ESPID Fellowship, European Society for Paediatric Infectious Diseases. Supervisor of recipient (Koen van Aerde).

2016-2019           PERFORM Personalised Risk assessment in febrile illness to Optimise Rela-life Management across the European Union. EU H2020 Project  Co-PI Radboudumc.

2012-2016           EUCLIDS European Childhood Life-threatening Infectious Disease Study . EU FP7  Investigator Radboudumc coordinator Dutch patient inclusion.